Intensive Blood Pressure Control and Diabetes Mellitus Incidence for Patients with Impaired Fasting Glucose: A Secondary Analysis of SPRINT.

Publication Year: 2023

DOI:
10.1155/2023/7533353

PMCID:
PMC10036175

PMID:
36968629

Journal Information

Full Title: Int J Hypertens

Abbreviation: Int J Hypertens

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Peripheral Vascular Disease

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflicts of Interest The authors declare that they have no conflicts of interest."

Evidence found in paper:

"The authors acknowledge the funding provided by the Project of Common Chronic Disease Education and Decision Support which was a cooperated effort between Ping An Healthcare and Technology Co., Ltd. and Zhongshan Hospital of Fudan University (H2020–027)."

Evidence found in paper:

"Conclusions: Our study found that in comparison to the standard BP control for hypertensive patients with IFG, intensive BP control was associated with a small increased risk of new-onset T2D, though it did not reach statistical significance. This kind of impact should be considered when implementing the strategy, especially for those with high risks of developing T2D. This trial is registered with NCT01206062. Ethical Approval: This study has been registered at https://www.clinicaltrials.gov, unique identifier: NCT01206062."

Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025